Noteworthy Price Action: iKang Healthcare Group Inc (ADR)’s Stock Is Sell After Achieving 52 Week Low

Noteworthy Price Action: iKang Healthcare Group Inc (ADR)'s Stock Is Sell After Achieving 52 Week Low

The stock of iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) hit a new 52-week low and has $14.97 target or 7.00% below today’s $16.10 share price. The 8 months bearish chart indicates high risk for the $1.09 billion company. The 1-year low was reported on Nov, 25 by Barchart.com. If the $14.97 price target is reached, the company will be worth $76.30 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 7.31% or $1.27 on November 25, hitting $16.1. About 765,736 shares traded hands or 267.66% up from the average. iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) has declined 19.28% since April 22, 2016 and is downtrending. It has underperformed by 24.69% the S&P500.

Analysts await iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) to report earnings on December, 1 after the close.

According to Zacks Investment Research, “iKang Healthcare Group, Inc. is engaged in providing preventive healthcare solutions in the People’s Republic of China. It offers medical examination, screening and other services. The Company primarily serves corporate and individual customers. It provides its services through self-owned medical centers and the facilities of third-party service providers. iKang Healthcare Group, Inc. is headquartered in Beijing, the People’s Republic of China.”

More notable recent iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) news were published by: Quotes.Wsj.com which released: “DOW JONES, A NEWS CORP COMPANY” on April 06, 2014, also Bloomberg.com with their article: “China’s IKang Rises to Seven-Month High as Bidding War Heats Up” published on January 06, 2016, Barrons.com published: “iKang’s Vital Signs Strong in China’s Testing Boom” on December 04, 2014. More interesting news about iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) were released by: Bloomberg.com and their article: “Tybourne Among Asia Hedge Funds Selling Chinese Company ADRs” published on February 19, 2016 as well as Reuters.com‘s news article titled: “iKang Healthcare Group Inc mGuizhou Wishstar Medical Center” with publication date: March 23, 2016.

KANG Company Profile

iKang Healthcare Group, Inc., incorporated on May 25, 2011, provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Firm operates through two divisions: medical examinations and other medical services, and dental services. As of March 31, 2016, its network across the nation consisted of 86 self-owned medical centers, and its self-owned medical center network covered 25 cities in China, such as Beijing, Shanghai, Guangzhou, Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou, Chengdu, Fuzhou, Changchun, Jiangyin, Changzhou, Shenyang, Changsha, Wuhan, Yinchuan, Yantai, Weihai, Weifang, Foshan, Xi’an, Wuhu and Guiyang, as well as Hong Kong. The Company’s network across the nation offers a range of medical examination services and provides a one-stop solution to its corporate customers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment